ReviewCardiology research2026
Application of Artificial Intelligence and Machine Learning in Arrhythmia Detection and Pacemaker Data Analysis.
Review in Cardiology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Driven by rapid advancements in computational power and algorithmic innovations, artificial intelligence (AI) and machine learning (ML) technologies have demonstrated significant potential in the field of cardiovascular medicine. This systematic review evaluates the applications of AI/ML in two key areas: arrhythmia detection and pacemaker data analytics. It examines the evolution of these technologies from traditional ML to deep learning, assessing their effectiveness in enhancing diagnostic accuracy, predicting clinical outcomes, and optimizing treatment strategies. Notably, this review supplements the practical application status of AI-augmented algorithms in mainstream clinical electrocardiogram (ECG) reading systems (represented by GE and Siemens platforms) in real-world clinical scenarios and systematically summarizes the latest research progress of AI-based intelligent analysis targeting pacemaker spike signals, which are easily ignored by conventional detection methods. The article also addresses current challenges, including technical limitations, barriers to clinical implementation, and ethical and regulatory considerations. Although issues such as data standardization, model interpretability, and external validation remain, AI/ML technologies already show transformative potential in arrhythmia management and pacemaker data utilization and are expected to play an increasingly central role in the future of personalized cardiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.